Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$5,001,176
+$125,088 QoQ
Shares Held
19,692
-1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.09%
of 13F equity value
Holder Rank
#1,620
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 14%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADIRONDACK TRUST CO holds $16,941,363 across 11 Drug Manufacturers - General names. JNJ ranks #1 (29.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
19,692 | $5,001,176 | |
| 2 | LLY |
ELI LILLY & Co
|
3,642 | $4,368,324 | |
| 3 | ABBV |
AbbVie Inc.
|
13,727 | $3,454,261 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
19,711 | $1,135,747 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,753 | $1,124,760 | |
| 6 | AMGN |
Amgen Inc
|
2,529 | $915,801 | |
| 7 | PFE |
Pfizer Inc
|
23,149 | $557,427 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,872 | $236,508 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,001,176 | 19,692 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,876,088 | 19,948 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $4,522,477 | 21,853 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $4,136,719 | 22,310 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $3,445,123 | 22,554 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $3,887,786 | 23,443 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $3,450,922 | 23,862 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $4,018,276 | 24,795 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $3,663,792 | 25,067 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $3,994,613 | 25,252 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $3,990,286 | 25,458 | Shares | Sole | 2024-03-29 | |
| 2023-09-30 | $4,103,545 | 26,347 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $4,386,610 | 26,502 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,115,560 | 26,552 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $4,708,251 | 26,653 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $4,346,846 | 26,609 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $4,622,715 | 26,042 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $4,570,052 | 25,786 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $4,226,454 | 24,706 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $4,035,400 | 24,987 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,117,675 | 24,995 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $4,110,229 | 25,009 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $3,697,957 | 23,497 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,568,802 | 23,971 | Shares | Sole | 2020-10-05 | |
| 2020-06-30 | $3,397,339 | 24,158 | Shares | Sole | 2020-08-19 | |
| 2020-03-31 | $3,200,620 | 24,408 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||